AN2 Therapeutics, Inc

ANTXNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

36.3M

on 2026-06-30, from 29.8M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2026-04-09. 2 prospectus supplements filed under it since. S-3 ↗

$80.0M

Jefferies, agreement of 2026-04-09. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

2.95M

Warrants of every class as tagged in the XBRL facts on 2025-12-31. 10-K ↗

Cash

10.2 quarters

$78.4M on 2026-06-30 ÷ $7.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-03-08	Private placement incl. 5.79M pre-funded	11,578,986	not read	$40.0M	8-K ↗